/ Print /

HOSPITAL & PROVIDER STRATEGY

Insurers benefit from getting on board with Cancer MoonShot 2020Drugs will be provided to health plan members on clinical trials free of charge.
Insurer: No more prior auths for opioid addiction medsAs part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder.
Fed up providers pursue provider-sponsored health plansA recent survey suggests suggest a lack of access to appropriate commercial payer arrangements is causing health systems to explore alternatives.
New cancer care approach: Highmark’s cancer collaborativeCancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.
Four ways the genomic data commons will advance cancer careA new cancer database, the Genomic Data Commons, aims to make research more accessible
Payers Can Help with the Joy of MedicinePayers have a direct interest in preserving independent physician practices and helping all physicians regain the Joy of Medicine.
Are ACA’s cost-sharing reduction plans effective?A new Commonwealth Fund study explores cost-sharing reduction plans and marketplace coverage.
Four ways clinical decision support can improve outcomesThe advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are.
Health policy experts predict election outcome, healthcare changesWhile healthcare has flown under the radar for much of this election season, it’s a topic that was not ignored at the Academy of Managed Care Pharmacy (AMCP) Nexus in National Harbor, Maryland.
Clinton lays out healthcare plan in NEJM; Trump opts outUnderstanding both candidates proposals can help executives make informed decisions.